The human correlation: studies of data obtained from a mouse model of IPF
The human correlation: studies of data obtained from a mouse model of IPF
批准号:
7690868
负责人:
CHRISTOPHER BARAN
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-19 至 2011-07-31
关键词:
AddressAlveolar MacrophagesAnimal Disease ModelsAreaBasic ScienceBindingBiologicalBiological AssayBiological MarkersBleomycinCCL2 geneCCL8 geneCellsCharacteristicsClinical DataClinical SciencesCollagenComplexCorrelation StudiesCytokine Receptor BindingDataDevelopmentDiseaseDrug DesignEnzyme-Linked Immunosorbent AssayFamilyFibrosisFutureGoalsGrantHamman-Rich syndromeHematopoietic Cell Growth FactorsHomologous GeneHumanImmunohistochemistryIn Situ HybridizationInflammatoryInterstitial Lung DiseasesInvestigationLeadLigandsLungMacrophage Colony-Stimulating FactorManuscriptsMedicalMessenger RNAMethodsMissionModelingMolecularMolecular ProfilingMonocyte Chemoattractant Protein-1MusMyofibroblastNational Heart, Lung, and Blood InstitutePathogenesisPathway interactionsPatientsPhenotypePlasmaProcessProspective StudiesProteinsPublishingPulmonary FibrosisRNARecording of previous eventsResearchResearch PersonnelRetrospective StudiesSamplingSchemeSeverity of illnessSpecimenStaining methodStainsStatistical ModelsStructure of parenchyma of lungSystemTherapeuticTherapeutic AgentsTimeTissuesTranslatingUnited States National Institutes of HealthWestern Blottingabstractingbeta-Chemokineschemokinecombathuman datahuman diseasehuman tissueindium-bleomycininsightmonocyte chemoattractant protein 1 receptormouse modelnovelprospectiveprotein expressionpublic health relevancetherapeutic targettranscription factortranslational study
中文摘要
描述(由申请人提供):
项目摘要/摘要:治疗或治愈人类疾病的能力取决于进行有价值和信息丰富的基础科学、临床科学和转化性研究的能力。对于特发性肺纤维化(IPF),许多研究人员利用基础科学模型来揭示围绕这种疾病发展的分子细节。这些模型是必不可少的,但它们受到这样一个事实的限制,即它们不能完全代表人类的表型,并作为一个人工系统发挥最好的功能。尽管对患有IPF的人类进行回顾性或前瞻性研究是极其困难的,但必须进行这些概念验证研究,以确认使用基础科学模型揭示的任何细节。目前还没有已知的IPF病因或治愈方法,但利用基础科学模型和人体组织对与这种疾病相关的分子途径进行表征,肯定会导致这种毁灭性疾病的新发现、治疗或治愈。这笔赠款的广泛和长期目标包括:1)提供人体标本的概念验证研究;2)更好地了解M-CSF、CCL8、CCL2和CCR2在人类IPF中的参与;3)深入了解IPF患者肺组织切片中纤维细胞的特征;4)利用所有现有的临床数据,将分子和细胞特征与疾病的缺失、存在和严重程度联系起来。为了实现这些目标,将使用以下三个具体目标:1)确定M-CSF、CCL8、CCL2和CCR2在IPF患者中的表达谱;2)表征和鉴定IPF患者肺组织切片中的纤维细胞;3)使用统计模型将收集的肺分子、表型数据与患者临床数据相关联。在这样做的时候,这些研究将优先于进一步研究这些因素作为可能的治疗药物来对抗肺纤维化,或者作为新的疾病生物标记物的预期用途,这与国家卫生研究院的国家心肺和血液研究所的使命相关。这笔赠款的目的和目的将通过以下方法实现。组织切片将用于免疫组织化学方法,如基本单一染色、复合双重免疫组织化学和原位杂交。组织切片也将被用来分离蛋白质和RNA,用于激活和表达分析,包括ELISA分析、Western blotting和Real time PCR。最后,患者的临床数据将被用来在疾病的存在或严重程度与从患者样本中获得的所有可量化数据之间进行统计关联。(摘要结束)
公共卫生相关性:
项目简介:这笔赠款的目的和目的包括使用特发性肺纤维化患者的标本,以促进更好地了解与疾病发展有关的过程。这将允许未来对一种未知病因或治愈的疾病的潜在治疗药物设计和/或疾病的生物标志物进行研究。
英文摘要
DESCRIPTION (provided by applicant):
Project Summary / Abstract: The ability to treat or cure a human disease depends upon the ability to perform valuable and informative basic science, clinical science, and translational studies. For the disease idiopathic pulmonary fibrosis (IPF), many researchers utilize basic science models to uncover the molecular details surrounding the development of this disease. These models are essential, but they are limited by the fact that they do not completely represent the human phenotype and function best as an artificial system. Although performing retrospective or prospective studies on humans with IPF is extremely difficult, these proof-of-concept studies must be done to confirm any details revealed from the use of basic science models. There is no known cause or cure for IPF, but the characterization of the molecular pathways associated with this disease, using both basic science models and human tissues, will certainly lead to a novel discovery, treatment, or cure for this devastating disease. The broad, long-term objectives of this grant include: 1) Provide proof-of-concept studies with human specimens; 2) Obtain a better understanding of the involvement of M-CSF, CCL8, CCL2, and CCR2 in human IPF; 3) Gain insight into the characteristics of fibrocytes in lung tissue sections from patients with IPF; 4) Correlate the molecular and cellular characteristics with the absence, presence, and severity of disease using all available clinical data. To achieve these goals, the following three specific aims will be used: 1) Determine the expression profiles of M-CSF, CCL8, CCL2, and CCR2 in patients with IPF; 2) Characterize and identify fibrocytes in lung tissue sections from patients with IPF; 3) Correlate the gathered lung molecular, phenotypic data to patient clinical data using statistical models. In doing so, these studies will lend precedence to further investigation of these factors as possible therapeutic agents to combat lung fibrosis, or for the prospective use as novel biomarkers of disease, which correlates with the mission of the National Heart, Lung, and Blood Institute of the National Institutes of Health. The objectives and aims of this grant will be accomplished by using the following methods. Tissue sections will be used for immunohistochemical methods, such as basic single staining, complex dual immunohistochemistry, and in situ hybridization. Tissue sections will also be used to isolate protein and RNA for activation and expression assays, including ELISA analysis, western blotting, and Real Time PCR. Lastly, patient clinical data will be used to perform statistical correlations between the presence or severity of disease and all quantifiable data obtained from patient specimens. (End of Abstract)
PUBLIC HEALTH RELEVANCE:
Project Narrative: The goals and objectives of this grant include the use of specimens from humans with idiopathic pulmonary fibrosis in order to facilitate a better understanding of the processes that are involved in the development of the disease. This will allow for future investigation into potential therapeutic drug design and/or biomarkers of disease for a disease that has no known cause or cure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金